z-logo
Premium
P4–263: Discovery of a regulatory site on beta–amyloid peptides
Author(s) -
Gadalla Moataz M.,
Hess George P.
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.2002
Subject(s) - chemistry , binding site , peptide , aptamer , ligand (biochemistry) , biochemistry , receptor , nicotinic acetylcholine receptor , pharmacology , acetylcholine receptor , biophysics , microbiology and biotechnology , biology
Recently, RNA polymers (aptamers) were isolated [1] that bind to a beta-amyloid peptide with 40 residues [A (1-40)] that is associated with Alzheimer’s disease. We analyzed the published sequences and found a consensus sequence similar to that of inhibitory RNA Class I aptamers we had previously isolated. The RNA Class I aptamers bind to an inhibitory cocaine-binding site of the nicotinic acetylcholine receptor (nAChR) [2]. Whole-cell current recordings, using the rapid-reaction, cell-flow technique [3], indicate that, as hypothesized, the aptamer that binds to the amyloid peptide also inhibits the nAChR in a dose-dependent manner. As a consequence, we determined whether A (1-40) binds cocaine. Electrophoretic mobility shift assays indicated that it does.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom